Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy

The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer therapy but only a fraction of patients benefits from this therapy. Model‐informed drug development can be used to assess prognostic and predictive clinical factors or biomarkers associated with treatment response. Most...

Descripción completa

Detalles Bibliográficos
Autores principales: Courlet, Perrine, Abler, Daniel, Guidi, Monia, Girard, Pascal, Amato, Federico, Vietti Violi, Naik, Dietz, Matthieu, Guignard, Nicolas, Wicky, Alexandre, Latifyan, Sofiya, De Micheli, Rita, Jreige, Mario, Dromain, Clarisse, Csajka, Chantal, Prior, John O., Venkatakrishnan, Karthik, Michielin, Olivier, Cuendet, Michel A., Terranova, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431051/
https://www.ncbi.nlm.nih.gov/pubmed/37328961
http://dx.doi.org/10.1002/psp4.12983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431051/
https://www.ncbi.nlm.nih.gov/pubmed/37328961
http://dx.doi.org/10.1002/psp4.12983

Ejemplares similares